ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Irinotecan-Teva liquid 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung - 
59217007 Teva Pharma AG
Irinotecan-Teva liquid 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung06.05.2009
Generic26.07.2011
Irinotecan (L01CE02) 
WHO-DDD 
07.16.10. 
07.16.10. 
A  
Yes 
IP 
245.64No
    
10 %298.70
  
7680592170072Synthetika
6985511 
Composition
irinotecani hydrochloridum trihydricum 300 mg, sorbitolum 675 mg, acidum (S)-lacticum, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 15 ml corresp. natrium 1.294 mg.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Irinotecan Hydrochloride Trihydrate300mg / 15ml
BAG: Active AgentDose
Irinotecan Hydrochloride Trihydrate300 mg
 
Inactive agentsDose
Acidum (S)-lacticum 
Acidum Hydrochloridum ad Ph 
Natrii Hydroxidum ad Ph 
Sorbitol675mg / 15ml
 
Source
Data was imported : 04.05.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home